Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBT: 2018-2025

Historic EBT for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to -$15.6 million.

  • Evolus' EBT rose 18.21% to -$15.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.8 million, marking a year-over-year decrease of 4.90%. This contributed to the annual value of -$49.8 million for FY2024, which is 19.11% up from last year.
  • Per Evolus' latest filing, its EBT stood at -$15.6 million for Q3 2025, which was up 8.89% from -$17.1 million recorded in Q2 2025.
  • Over the past 5 years, Evolus' EBT peaked at $6.4 million during Q1 2021, and registered a low of -$23.4 million during Q2 2022.
  • Over the past 3 years, Evolus' median EBT value was -$15.6 million (recorded in 2025), while the average stood at -$14.8 million.
  • Its EBT has fluctuated over the past 5 years, first surged by 132.92% in 2021, then slumped by 372.93% in 2022.
  • Quarterly analysis of 5 years shows Evolus' EBT stood at -$18.2 million in 2021, then rose by 27.86% to -$13.1 million in 2022, then rose by 10.54% to -$11.7 million in 2023, then soared by 45.83% to -$6.4 million in 2024, then increased by 18.21% to -$15.6 million in 2025.
  • Its EBT stands at -$15.6 million for Q3 2025, versus -$17.1 million for Q2 2025 and -$18.8 million for Q1 2025.